ENTRY LEVEL

Process Validation for Biotechnological Products

In-House Training

TRAINING OVERVIEW

This course will cover the definition of QbD concept and process validation, describing all key studies and scientific requirements for developing your biotechnological product. It will describe FDA and European guidelines, including the review of the IND and CTD documents, in term of regulatory expectations, to guide you to the market registration of your product.

  • Understand the purpose of process validation and its 3 stages

  • Learn regulatory guidelines related to process validation activities for drug substance and drug product

  • Understand how to set-up a control strategy

  • Examine how to assess microbiological risks (including viruses) during manufacturing

  • Discover studies that need to be performed prior to BLA

  • Learn keys to drive a process validation project to success

  • Process development scientists and managers

  • CMC development program managers

  • Pharmaceutical development scientists

  • Pharmaceutical development managers

  • Manufacturing managers

  • QC and stability control managers

  • Heads of Quality Assurance

  • Drug Regulatory Affairs managers

AGENDA

Introduction

  • Purpose of process validation

  • QbD concept and design space as new paradigm

Regulatory Considerations

  • Common Technical Document (CTD)

  • Regulatory guidelines

Overview of Process Validation

  • Documentation and studies for the BLA

  • Stage 1: Process Design

  • Stage 2: Process Performance Qualifaction

  • Stage 3: Continued Process Verification

Cell bank system qualification

Viral clearance

Safety aspects

Case studies

How to drive a process validation project to success

Questions and answers

Interested in this course?

Please contact us at mylene.talabardon@biotechnologyconsultant.com